The DOI matches its Crossref record.
Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group
Open accessAbstract
The Multicenter Diltiazem Postinfarction Trial (MDPIT) reported no consistent diltiazem effect on new or worsened congestive heart failure (CHF) during 12-52 months' follow-up after acute myocardial infarction. This was puzzling in light of the observation that patients with findings suggesting left ventricular dysfunction (LVD) at baseline on diltiazem had more cardiac events (cardiac mortality or recurrent nonfatal infarction) than such patients on placebo. We hypothesized that diltiazem increased the frequency of late CHF as well as of cardiac events, but only in patients predisposed by LVD. Using the same characterizing variables as the primary MDPIT analysis, we found that patients with pulmonary congestion, anterolateral Q wave infarction, or reduced ejection fraction (EF) at baseline were more likely to have CHF during follow-up than those without these markers of LVD. CHF was particularly frequent in the patients with LVD who were randomized to diltiazem. Among those with a baseline EF of less than 0.40, late CHF appeared in 12% (39/326) receiving placebo and 21% (61/297) receiving diltiazem (p = 0.004). Life table analysis in patients with an EF of less than 0.40 confirmed more frequent late CHF in those taking diltiazem (p = 0.0017). In addition, the diltiazem-associated rise in the frequency of late CHF was progressively greater with increasingly severe decrements in baseline EF. This diltiazem effect was absent in patients with pulmonary congestion at baseline but an EF of 0.40 or more, suggesting a unique association between diltiazem-related late CHF and systolic LVD.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as diltiazem and verapamil can have negative inotropic effects in patients with LVEF < 40%.222,534,535”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [535]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 14
- Hossack KF, Pool PE, Steel P, Crawford MH, DeMaria AN, Cohen LS, Ports TA: Efficacy of diltiazem in angina on effort: A multicenter trial. Am J Cardiol 1982;49:567-572
- Strauss WE, McIntyre KM, Parisi AF, Shapiro W: Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trial. Am J Cardiol 1982;49:560-566
- Pepine CJ, Feldman RL, Hill JA, Conti CR, Mehta J, Hill C, Scott E: Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil. Am Heart J 1983;106:1341-1347
- Boden WE, Bough EW, Reichman MJ, Rich VB, Young PM, Korr KS, Schulman RS: Beneficial effects of high-dose dil- tiazem in patients with persistent effort angina on p-blockers and nitrates: A randomized, double-blind, placebo-controlled cross-over study. Circulation 1985;71:1197-1205
- Porter CB, Walsh RA, Badke FR, O'Rourke RA: Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload. Circulation 1983;68:685-692
- Murakami T, Hess OM, Krayenbuehl HP: Left ventricular function before and after diltiazem in patients with coronary artery disease. JAm Coll Cardiol 1985;5:723-730
- The Multicenter Diltiazem Postinfarction Trial Research Group: The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-392
- Greenberg H, Gillespie J, Dwyer EM Jr, the Multicenter Post-Infarction Research Group: A new electrocardiographic classification for post-myocardial infarction clinical trials. Am J Cardiol 1987;59:1057-1063
- Kaplan EL, Meier P: Nonparametric estimation from incom- plete observations. JAm Stat Assoc 1958;53:457-481
- Marcus FI, Friday K, McCans J, Moon T, Hahn E, Cobb L, Edwards J, Kuller L: Age-related prognosis after acute myo- cardial infarction (the Multicenter Diltiazem Post-Infarction Trial). Am J Cardiol 1990;65:559-566
- Chadda K, Goldstein S, Byington R, Curb JD: Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-510
- Packer M, Gottlieb SS, Kessler PD: Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. The basis of a new physiologic approach to control of arrhythmia. Am J Med 1986;80:23-29
- Packer M, Meller J, Medina N, Yushak M, Smith H, Holt J, Guererro J, Todd GD, McAllister RG Jr, Gorlin R: Hemody- namic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation 1982;65:660-668
- Joshi PI, Dalal JJ, Ruttlet MSJ, Sheridan DJ, Henderson AH: Nifedipine and left ventricular function in beta-blocked patients. Br Heart J 1981;45:457-459
Cited by
Sorted by citations
Items 401–500 of 525
Principles of Outpatient Care of Patients With Heart Failure
Drapkina, O. M., & Chesnikova, A. I. (2024) · Kardiologiia · doi:10.18087/cardio.2024.11.n2797 · Cited by 2
Gori, M., Fazzini, L., Meessen, J. M. T. A., Limonta, R., Carigi, S., Bianco, M., Gennaro, L. D., Nora, C. D., Manca, P., Matassini, M. V., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106589 · Cited by 2
Calcium channel blockers in heart failure: Help or hindrance?
Konstam, M. A., Smith, J. J., Patten, R. D., & Udelson, J. E. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80085-6 · Cited by 2
Medical management of mild-to-moderate heart failure before the advent of beta blockers
Abraham, W. T., & Wagoner, L. E. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00386-6 · Cited by 2
Maintien à; domicile des personnes âgées
Magnier, A. (2006) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(06)75290-5 · Cited by 2
Rahko, P. S., Silver, M. A., Stevenson, L. W., Francis, G. S., Ganiats, T. G., Konstam, M. A., Jessup, M. L., Abraham, W. T., & Casey, D. E. (2009) · Cited by 2
Ostroumova, O. D., & Васильевна, Г. И. (2020) · Safety and Risk of Pharmacotherapy · doi:10.30895/2312-7821-2020-8-1-23-35 · Cited by 2
Arrhythmias in Children and Patients with Congenital Heart Disease
Lopez, M. M., & Kanter, R. J. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-41967-7_29 · Cited by 2
The Role of Neurohormonal Antagonists in Hibernating Myocardium
Lahiri, A., Senior, R., & Khattar, R. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199906003-00002 · Cited by 2
Problems with polypharmacy, alternative therapies and medication adherence
Forsyth, P., & McGlynn, S. (2022) · doi:10.1093/med/9780198766223.003.0056 · Cited by 2
Cost‐Effectiveness of Antihypertensive Agents in Patients With Reduced Left Ventricular Function
Arnold, R. J. G., Kaniecki, D. J., & Frishman, W. H. (1994) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1994.tb02805.x · Cited by 2
Pharmacologic Management of Chronic Heart Failure: A Review
Abraham, W. T. (1998) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/108925329800200302 · Cited by 2
Practical Issues in the Treatment of Patients with Heart Failure
Gattis, W. A. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.18.385s.34609 · Cited by 2
Chemical and epidemiological aspects of modified butter oil fractions
Fouad, F. M., Mamer, O., Sauriol, F., & Shahidi, F. (1998) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937409809524549 · Cited by 2
Bech, J. W., Madsen, J. K., & Kelbæk, H. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00052-5 · Cited by 2
LaForest, S. (2000) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200007000-00005 · Cited by 2
Effect of amlodipine on morbidity and mortality in severe chronic heart failure
Packer, M. (1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83285-0 · Cited by 2
Čatipović-Veselica, K. (1999) · Psychological Reports · doi:10.2466/pr0.84.2.433-442 · Cited by 2
Pharmacology of calcium channel antagonists
Triggle, D. J. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-3990-8_23 · Cited by 2
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure—Therapy or Futility?
Golan, Y. B.-B., & Lambiase, P. D. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0870 · Cited by 1
Pathophysiologie der chronischen Herzinsuffizienz
Böhm, M., & Erdmann, E. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_29 · Cited by 1
The Pilot European Survey of Atrial Fibrillation: How to Look at Heart Failure Through a Keyhole
Grigioni, F., & Senni, M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.293 · Cited by 1
Beaucage, P., Massicotte, J., Boileau, J.-F., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200307000-00022 · Cited by 1
Cardiac Remodeling: From Concepts to Therapeutics
Feuerstein, G., & Weck, P. K. (1999) · Heart Failure Reviews · doi:10.1023/a:1009847532728 · Cited by 1
Management of the Spectrum of Essential Hypertension: A 2013 Perspective
Riella, C. V., & Steinman, T. I. (2013) · Cardiovascular Pharmacology Open Access · doi:10.4172/2329-6607.1000112 · Cited by 1
Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Cited by 1
Self-citationYancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
Medications to Avoid in Acute Decompensated Heart Failure
Solomon, R. A., & McCord, J. (2017) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-017-0134-5 · Cited by 1
Atrial arrhythmias in heart failure with a reduced ejection fraction
Dewland, T. A., & Nazer, B. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000734 · Cited by 1
“Nondihydropyridine calcium channel blockers are to be avoided, as these medications have been associated with increased mortality when used in the setting of HFrEF [12].”
BackgroundPiszczatoski, C., & Smith, S. M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1915289 · Cited by 1
Montana, P. C., Rubin, P., Dyal, M. D., & Goldberger, J. J. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000585 · Cited by 1
“16 Notably, there were no data on heart failure decompensation or adverse outcomes during the index hospitalization because the initial follow-up was 3 months postdischarge, leaving a gap in our knowledge about the acute effects of NDCCBs in this post-MI patient population.”
Evolving targets for heart failure: the journey so far
Rosano, G. M. C., & Farkaš, J. (2023) · Global Cardiology · doi:10.4081/globcardio.2023.6 · Cited by 1
Evolving targets for heart failure: the journey so far
Rosano, G. M. C., & Farkaš, J. (2023) · Global Cardiology · doi:10.4081/globalcard.2023.6 · Cited by 1
Baba, Y., Kubo, T., Kawada, K., Ochi, Y., Hirota, T., Yamasaki, N., & Kitaoka, H. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5288-25 · Cited by 1
“This contraindication is based on Gold-stein’s report that diltiazem increases late-onset congestive heart failure in post-infarction patients with early reduction in ejection fraction (2).”
Position paper FADOI sulla prevenzione cardiovascolare nei pazienti complessi a rischio
Campanini, G. E. M., Nardi, R., & Pinna, G. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.q.2015.4 · Cited by 1
Жиров, И. В., Nikolaeva, O. A., & Tereshchenko, S. N. (2013) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2013-6-29-33 · Cited by 1
Drug Treatment of Stable Coronary Artery Disease
Aronow, W. S., & Frishman, W. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802385-3.00015-2 · Cited by 1
Clarity and controversy around rate control in AF, the orphan child in AF therapeutics
Aguilar, M., & Nattel, S. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.024 · Cited by 1
Self-citationThe impact of medical therapy on left ventricular strain: Current state and future perspectives
Карев, Е. А., Verbilo, S. L., Malev, E. G., & Прокудина, М. Н. (2022) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23244 · Cited by 1
Pharmacologic Management of Heart Failure: Neurohormonal Agents
Moser, D. K. (1993) · Critical Care Nursing Clinics of North America · doi:10.1016/s0899-5885(18)30528-8 · Cited by 1
Cardiac Changes in the Elderly
Aronow, W. S., & Frishman, W. H. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0892-6_21 · Cited by 1
Acute congestive heart failure: pathophysiological alterations
Dahlen, R., & Roberts, S. L. (1995) · Intensive and Critical Care Nursing · doi:10.1016/s0964-3397(95)80109-x · Cited by 1
Depression in the Post-Myocardial Infarction Patient
Felker, B. L., Shores, M. M., & Gibbon, K. L. (1998) · Medical Update for Psychiatrists · doi:10.1016/s1082-7579(98)00015-6 · Cited by 1
Moser, D. K., & Biddle, M. (2003) · Critical Care Nursing Clinics of North America · doi:10.1016/s0899-5885(02)00107-7 · Cited by 1
Hori, M., Sato, H., Karita, M., et al. (1994) · Heart and Vessels · doi:10.1007/bf01745105 · Cited by 1
Management of Atrial Fibrillation in Patients With Congestive Heart Failure
Sturmer, M., Talajic, M., Thibault, B., et al. (2005) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2005.02284.x · Cited by 1
Digoxin, Diuretics, and Vasodilators in Patients with Heart Failure
Marti, C. N., Cole, R., Giamouzis, G., & Butler, J. (2015) · Springer eBooks · doi:10.1007/978-1-4471-6657-3_4 · Cited by 1
An update on pulmonary arterial hypertension.
Karki, D., Neopane, A., & Regmi, S. (2008) · PubMed · Cited by 1
Medical Management of Chronic Heart Failure: Direct-Acting Vasodilators and Diuretic Agents
Cuny, J., & ENGER, E. L. (1993) · Critical Care Nursing Clinics of North America · doi:10.1016/s0899-5885(18)30526-4 · Cited by 1
Role of Vasodilator Therapy in Congestive Heart Failure: Effects on Mortality
Barry, G. (1994) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30128-0 · Cited by 1
Physiologic Changes in Cardiac Function with Aging
Aronow, W. S., & Frishman, W. H. (2001) · Springer eBooks · doi:10.1007/978-1-4757-3432-4_30 · Cited by 1
Akute kardiale Dyspnoe und Lungenödem
Beuckelmann, D. J. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_27
Leitliniengestützte Therapie der Herzinsuffizienz
Uc, H., & Erdmann, E. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Cardioprotection by Calcium Antagonists: Myocardial Ischemia and Secondary Prevention
Hansen, J. F., & Andersen, L. T. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0117-2_13
Standard Medical Therapy of Heart Failure
Yamani, M. H. (2007) · Heart failure · doi:10.1002/9780470994795.ch3
Efremidis, M., & Pappas, L. K. (2009) · Hospital chronicles/Hospital Chronicles
Physiologic Changes in Cardiac Function with Aging
Aronow, W. S., & Frishman, W. H. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6999-6_50
Heart failure and chronic obstructive pulmonary disease : common partners, common problems.
Hawkins, N. M. (2010) · Enlighten: Theses (The University of Glasgow)
Oxidative Stress and Use of Antioxidants in Patients with Congestive Heart Failure
White, M., Tardif, J., & Bourassa, M. G. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-4375-2_14
Singh, C., & Singh, M. V. (2013) · International Journal of Pharmacological Research · doi:10.7439/ijpr.v3i3.52
Iwaki, K., Nakashima, M., & Kishi, M. (1997) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1997.tb00338.x
Cox, A. R., & Langford, N. (2003) · Adverse Drug Reaction Bulletin · doi:10.1097/00012995-200306000-00001
“Page and Henry5 conducted a matched case-control study of the relationship between recent use of NSAIDs and hospitalization with CHF.”
BackgroundInfluentialPrise en charge de l'insuffisance cardiaque des personnes âgées
Émeriau, J. P., & Lamouliatte, F. (2008) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(07)37771-5
Gestione dell’insufficienza cardiaca delle persone anziane
Émeriau, J. P., & Lamouliatte, F. (2008) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(08)70372-3
All calcium channel blockers are not alike
Cheng, T. O. (1991) · International Journal of Cardiology · doi:10.1016/0167-5273(91)90338-p
The Year in Review: Cardiology
Sanoski, C. A. (2001) · Journal of Pharmacy Practice · doi:10.1106/76jd-3quw-w0cv-95mk
Winkelmann, B. R., Haak, T., Verho, M., et al. (1996) · Current Therapeutic Research · doi:10.1016/s0011-393x(96)80002-6
Russo, R., Rao, M. A. E., Mele, A., et al. (1998) · Current Therapeutic Research · doi:10.1016/s0011-393x(98)85069-8
Tratamiento de la insuficiencia cardíaca del anciano
Émeriau, J. P., & Lamouliatte, F. (2008) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(08)70599-3
Pharmacologic Therapy for Symptomatic Congestive Heart Failure
Loh, E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-347-7_14
β-adrenoceptor antagonists and antianginal drugs
Maggioni, A. P., Franzosi, M., & Latini, R. (2000) · Side effects of drugs annual · doi:10.1016/s0378-6080(00)80024-0
Pharmacologic Management of Atrial Fibrillation and Flutter
Saluja, D. S., Hickey, K. T., & Reiffel, J. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-161-5_8
Medical Therapy for Heart Failure
Lakdawala, N. K., & Desai, A. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-424-7_2
Medical treatment beyond ACE inhibition: false promise or lack of vision?
Walsh, J. T., & Cowley, A. (1994) · Heart · doi:10.1136/hrt.72.3_suppl.s100
Second generation dihydropyridine calcium channel blockers for heart failure
van Marum, R. J., Zwinderman, A. A., & Cleophas, A. J. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003835.pub2
Drugs to Avoid in Acute Heart Failure: Contraindicated Medications and Interactions
McCord, J. (2012) · Contemporary cardiology · doi:10.1007/978-1-61779-627-2_19
Chen, Y., Zhu, W., Zhong, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6086
Calciumantagonisten bei chronischer Herzinsuffizienz
Strasser, R. H. (1996) · Steinkopff eBooks · doi:10.1007/978-3-642-93678-4_14
Present Aspects of Vasodilator Therapy
Ito, H., Gotoh, K., Minatoguchi, S., et al. (1993) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.57.supplementiv_1367
DILTIAZEM INCREASES LATE HEART FAILURE IN POST-MI PATIENTS WITH LV DYSFUNCTION.
Thl (1991) · Journal watch · doi:10.1056/jw199101180000001
Massie, B. M., & Amidon, T. M. (1994)
Evaluation and Management of Arrhythmias Associated with Congestive Heart Failure
Singh, S. N. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00058-2
Kliger, C., Schwartzbard, A. Z., Fisher, E., & WEINTRAUB, H. S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00011-1
Lewis, B. S., & Gheorghiade, M. (2007) · CRC Press eBooks · doi:10.3109/9780203463048-39
Is Heart Rate a Norepiphenomenon in Heart Failure?
Hensey, M., & O’Neill, J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0764-3
Definition und Epidemiologie der chronischen Herzinsuffizienz
Böhm, M., & Erdmann, E. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_28
The Ever Expanding Spectrum Ventricular Dysfunction of Ischemic Left
Opie, L. H. (1994)
Breitenstein, A., & Steffel, J. (2017) · Praxis · doi:10.1024/1661-8157/a002725
Cardiac Disease in Older Adults
Aronow, W. S., & Frishman, W. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-20317-1_15-1
Traitement de l'insuffisance cardiaque
Capelle, A., Armoiry, X., & Aulagner, G. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-75077-9.00010-4
Acute Coronary Syndromes and Acute Myocardial Infarction
Werns, S. W. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50033-9
Byrnes, T. J., & Huang, D. T.-C. (2020) · Hypertension Journal · doi:10.15713/ins.johtn.0176 · Cited by 3
“(degree 4 hypertensive heart disease), calcium channel blocking agents,[60-62] Class I agents,[63] sotalol,[64] and dronedarone[65]”
BackgroundThe role of calcium antagonists in the treatment of cardiovascular disease: Focus on diltiazem
Барышникова, Г. А., Chorbinskaya, S. A., & Stepanova, I. I. (2015) · Cardiosomatics · doi:10.26442/cs45175
Hogan, T. M. (1997) · Springer eBooks · doi:10.1007/978-1-4757-2705-0_11
Erdmann, E. (2005) · Springer eBooks · doi:10.1007/3-540-29425-2_5
Section 13: Evaluation and Therapy for Heart Failure in the Setting of Ischemic Heart Disease
Heart Failure Society of America (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.11.018
Haas, G. J., & Leier, C. V. (1994) · Congestive Heart Failure · doi:10.1007/978-1-4613-8315-4_24
Metadata
- Authors
- Goldstein, R. E., Boccuzzi, S. J., Cruess, D., & Nattel, S.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- Venue
- Circulation
- Published
- 1991-01
- Volume
- 83
- Issue
- 1
- Pages
- 52-60
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2090674352
- Cited by
- 521
- References
- 0
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 16 · 2021: 7 · 2020: 24 · 2019: 13 · 2018: 15 · 2017: 17 · 2016: 15 · 2015: 17 · 2014: 4 · 2013: 16 · 2012: 11
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Henry M. Jackson Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- diltiazem, congestive heart failure, myocardial infarction, left ventricular dysfunction, ejection fraction, calcium channel blockers, pulmonary congestion, adverse drug reactions
- MeSH terms
- Diltiazem, Double-Blind Method, Follow-Up Studies, Heart Failure, Humans, Myocardial Infarction, Stroke Volume, Life Tables, Ventricular Function, Left
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
